跳至主要内容
临床试验/NCT01611025
NCT01611025Unknown不适用

The Impact on the Hospital's Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic, Using Antibiotic Utilization and Hospital Susceptibility Data Over Time

Taipei Veterans General Hospital, Taiwan0 个研究点目标入组 30,000 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
30,000

研究概览

简要总结

This is a retrospective, multicentre, observational study to assess the trends in antibiotic utilization and hospital ecology with respect to susceptibility patterns of selected bacterial isolates to the utilized antibiotics.

详细描述

This is a retrospective, multicentre, observational study to assess the trends in antibiotic utilization and hospital ecology with respect to susceptibility patterns of selected bacterial isolates to the utilized antibiotics.

There will be two sets of data collected: Hospital acquired infection (only the first pathogen cultured of each episode) and All infection (the whole hospital susceptibility data)

Primary Objectives:

  1. To study the impact of the introduction of ertapenem on the susceptibility pattern of various pathogens to imipenem/meropenem.
  2. To study the impact of the introduction of ertapenem on the susceptibility of all Gram negative bacilli to antimicrobial agents commonly used in the participated study sites.
  3. To explore the trend in antimicrobial utilization before and after the introduction of new antimicrobial agents to the hospital formulary during the index period.

Secondary Objectives:

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • the susceptibility of Pseudomonas aeruginosa
  • the susceptibility of Escherichia coli (ESBL and Non-ESBL producing strains)
  • the susceptibility of Klebsiella pneumoniae(ESBL and Non-ESBL producing strains)
  • the susceptibility of Enterobacter cloacae
  • the susceptibility of Enterobacter aerogenes
  • the susceptibility of Acinetobacter baumannii
  • antibiotic utilization data of carbapenems: Ertapenem, Meropenem, Imipenem
  • antibiotic utilization data of Penicillins: Piperacillin/Tazobactam
  • antibiotic utilization data of cephalosporins: Ceftriaxone, Cefotaxime, Flomoxef, Cefoperazone, Ceftazidime, cefepime, Cefpirome
  • antibiotic utilization data of Aztreonam,
  • antibiotic utilization data of fluoroquinolones: Ciprofloxacin, Levofloxacin
  • antibiotic utilization data of aminomethylcyclines: Tigecycline

排除标准

  • 未提供

研究者

申办方类型
Other Gov
责任方
Sponsor

相似试验

Hospital Microbial Ecology Follow the Introduction... | 临床试验